The risk of valve thrombosis is higher with intra-annular versus supra-annular transcatheter aortic valve prosthesis. A meta-analysis from randomized controlled trials

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. 1.

    Ng ACT, Holmes DR, Mack MJ et al (2020) Leaflet immobility and thrombosis in transcatheter aortic valve replacement. Eur Heart J 41:3184–3197

    Article  Google Scholar 

  2. 2.

    Rashid HN, Nasis AM, Gooley RP, Cameron JD, Browon AK (2018) The prevalence of computed tomography-defined leaflet thrombosis in intra- versus supra-annular transcatheter aortic valve prosthesis. Cathet Cardiovasc Interv 92:1414–1416

    Article  Google Scholar 

  3. 3.

    Abdel-Wahab M, Landt M, Neumann FJ et al (2020) CHOICE Investigators. 5-Year outcomes after TAVR with balloon-expandable versus self-expanding valves: results from the CHOICE randomized clinical trial. JACC Cardiovasc Interv 13:1071–1082

    Article  Google Scholar 

  4. 4.

    Kooistra NHM, Abawi M, Voskuil M et al (2020) Randomised comparison of a balloon-expandable and self-expandable valve with quantitative assessment of aortic regurgitation using magnetic resonance imaging. Neth Heart J 28:253–265

    CAS  Article  Google Scholar 

  5. 5.

    Reardon MJ, Feldman TE, Meduri CU et al (2019) Reprise III. Investigators two-year outcomes after transcatheter aortic valve replacement with mechanical vs self-expanding valves: the REPRISE III randomized clinical trial. JAMA Cardiol 4:223–229

    Article  Google Scholar 

  6. 6.

    Lanz J, Kim WK, Walther T et al (2019) SCOPE I investigators. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet 394:1619–1628

    Article  Google Scholar 

  7. 7.

    Thiele H, Kurz T, Feistritzer HJ et al (2020) Comparison of newer generation self-expandable vs balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Eur Heart J 41:1890–1899

    CAS  Article  Google Scholar 

  8. 8.

    Midha PA, Raghav V, Sharma R et al (2017) The fluid mechanics of transcatheter heart valve leaflet thrombosis in the neosinus. Circulation 136:1598–1609

    Article  Google Scholar 

  9. 9.

    Jander N, Sommer H, PingPoh C et al (2015) The porcine valve type predicts obstructive thrombosis beyond the first three postoperative months in bioprosthesis in the aortic position. Int J Cardiol 199:90–95

    Article  Google Scholar 

  10. 10.

    Dangas GD, Tijssen JGP, Wöhrle J et al (2020) GALILEO Investigators. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med 382:120–129

    CAS  Article  Google Scholar 

  11. 11.

    Moreno R, Calvo L, Salinas P et al (2011) Causes of peri-operative mortality after transcatheter aortic valve implantation: a pooled analysis of 12 studies and 1223 patients. J Invasive Cardiol 23:180–184

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Raúl Moreno.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Moreno, R., Unverdorben, M., Jurado-Román, A. et al. The risk of valve thrombosis is higher with intra-annular versus supra-annular transcatheter aortic valve prosthesis. A meta-analysis from randomized controlled trials. Clin Res Cardiol (2021). https://doi.org/10.1007/s00392-021-01818-x

Download citation